Progesterone

Generic Name
Progesterone
Brand Names
Bijuva, Crinone, Endometrin, Prochieve, Prometrium
Drug Type
Small Molecule
Chemical Formula
C21H30O2
CAS Number
57-83-0
Unique Ingredient Identifier
4G7DS2Q64Y
Background

Progesterone is a hormone that occurs naturally in females, and is essential for endometrial receptivity, embryo implantation, and the successful establishment of pregnancy. A low progesterone concentration or an insufficient response to progesterone can cause infertility and pregnancy loss . Progesterone is used in various contraceptive preparations to prevent ovulation and fertilization , as well as in other formulations to promote and support pregnancy. Please see Medroxyprogesterone acetate, Megestrol acetate, Dydrogesterone and Hydroxyprogesterone entries for information on various other forms of progesterone.

Pharmaceutical progesterone is made from a plant source as a starting material and is chemically identical to progesterone of human ovarian origin . Progesterone is available in gelatinized capsule form, vaginal gel form, tablet form, vaginal insert form, and injection form, all used for various purposes .

Indication

Gelatinized capsules

The gelatinized capsules are indicated for use in the prevention of endometrial hyperplasia in non-hysterectomized postmenopausal women who are receiving conjugated estrogens tablets. They are also indicated for use in secondary amenorrhea .

Vaginal gel

Progesterone gel (8%) is indicated as progesterone supplementation or replacement as part of an Assisted Reproductive Technology (“ART”) treatment for infertile women with progesterone deficiency. The lower concentration progesterone gel (4%) is used in the treatment of secondary amenorrhea, with the use of the 8% concentration if there is no therapeutic response to the 4% gel .

Vaginal insert

This form is indicated to support embryo implantation and early pregnancy by supplementation of corpus luteal function as part of an Assisted Reproductive Technology (ART) treatment program for infertile women .

Injection (intramuscular)

This drug is indicated in amenorrhea and abnormal uterine bleeding due to hormonal imbalance in the absence of organic pathology, such as submucous fibroids or uterine cancer .

Tablets, contraceptive

The tablet form of progesterone in contraceptive formulations is indicated for the prevention of pregnancy .

Associated Conditions
Abnormal Uterine Bleeding, Amenorrhea, Endometrial hyperplasia caused by conjugated estrogen, Moderate to Severe Vasomotor Symptoms, Pregnancy, Secondary Amenorrhea, Recurrent spontaneous preterm birth
Associated Therapies
Assisted Reproductive Technology therapy

Does Oral Micronized Progesterone Shorten Time of Symptoms From Concussion

Phase 4
Completed
Conditions
Interventions
First Posted Date
2013-03-13
Last Posted Date
2018-08-28
Lead Sponsor
Wake Forest University Health Sciences
Target Recruit Count
25
Registration Number
NCT01809639
Locations
🇺🇸

Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States

Progesterone & Postpartum Relapse to Smoking

First Posted Date
2013-02-25
Last Posted Date
2017-01-09
Lead Sponsor
University of Minnesota
Target Recruit Count
46
Registration Number
NCT01798394
Locations
🇺🇸

University of Minnesota, 717 Delaware Street SE, Minneapolis, Minnesota, United States

Progesterone Suppression of Nocturnal LH Increases in Pubertal Girls

Phase 1
Completed
Conditions
Interventions
First Posted Date
2013-01-23
Last Posted Date
2020-10-14
Lead Sponsor
University of Virginia
Target Recruit Count
14
Registration Number
NCT01773772
Locations
🇺🇸

University of Virginia Center for Research in Reproduction, Charlottesville, Virginia, United States

Neurophysiology of Postpartum Depression in an Experimental Model of Pregnancy and Parturition

First Posted Date
2013-01-08
Last Posted Date
2017-11-20
Lead Sponsor
University of North Carolina, Chapel Hill
Target Recruit Count
36
Registration Number
NCT01762943
Locations
🇺🇸

University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States

Sex Differences, Hormones & Smoking Cessation

First Posted Date
2012-12-06
Last Posted Date
2019-07-12
Lead Sponsor
University of Minnesota
Target Recruit Count
216
Registration Number
NCT01744574
Locations
🇺🇸

Delaware Clinical Research Unit, University of Minnesota, Minneapolis, Minnesota, United States

Progesterone and Atomoxetine for Cocaine Cessation

Not Applicable
Withdrawn
Conditions
Interventions
First Posted Date
2012-12-04
Last Posted Date
2019-09-06
Lead Sponsor
University of Minnesota
Registration Number
NCT01741376
Locations
🇺🇸

University of Minnesota, Minneapolis, Minnesota, United States

Pr-conceptional Progesterone for Unexplained Recurrent Miscarriage

Phase 4
Completed
Conditions
Interventions
First Posted Date
2012-08-22
Last Posted Date
2016-04-05
Lead Sponsor
Woman's Health University Hospital, Egypt
Target Recruit Count
700
Registration Number
NCT01670929
Locations
🇪🇬

Women's Health Hospital, Assiut, Egypt

Effects of Progesterone on IV Nicotine Induced Changes on BOLD fMRI Signal, Hormones and Subjective Ratings of Stimulant Drugs

Not Applicable
Withdrawn
Conditions
Interventions
First Posted Date
2012-05-01
Last Posted Date
2024-01-17
Lead Sponsor
Mclean Hospital
Registration Number
NCT01589068
Locations
🇺🇸

Alcohol and Drug Abuse Research Center at McLean Hospital, Belmont, Massachusetts, United States

Effects of Progesterone on IV Nicotine-Induced Changes in Hormones and Subjective Ratings of Stimulant Drug Effect

Not Applicable
Withdrawn
Conditions
Interventions
First Posted Date
2012-05-01
Last Posted Date
2024-01-17
Lead Sponsor
Mclean Hospital
Registration Number
NCT01589081
Locations
🇺🇸

Alcohol and Drug Abuse Research Center at McLean Hospital, Belmont, Massachusetts, United States

© Copyright 2024. All Rights Reserved by MedPath